Clinical trial NCT01157650 - References

Crohn Disease — Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue

Citation(s)

•   Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, Prieto Martínez C, Martínez Echeverría A, Elizalde Apestegui I, Laiglesia Izquierdo M, Macias Mendizábal E, Tamburri Moso P, Sánchez Valverde F
  [High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study]. Gastroenterol Hepatol. 2008 Mar;31(3):111-6. Spanish.
•   Brullet E, Bonfill X, Urrútia G, Ruiz Ochoa V, Cueto M, Clofent J, Martínez Salmerón JF, Riera J, Obrador A
  [Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease]. Med Clin (Barc). 1998 May 16;110(17):651-6. Spanish.
•   García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA
  A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005 Jul;48(7):1416-23.
•   García-Olmo D, Trébol J, et al
  Treatment of digestiva fistula using Adipose-derived Stem Cells. In: García-Olmo D, García-Verdugo JM, Alemany J, Gutierrez-Fuentes JA, editors. Cell Therapy. Madrid: McGraw-Hill. Interamericana; 2008. p. 289-307.
•   Gardiner KR, Dasari BV
  Operative management of small bowel Crohn's disease. Surg Clin North Am. 2007 Jun;87(3):587-610. Review.
•   Gelbmann CM, Rogler G, Gross V, Gierend M, Bregenzer N, Andus T, Schölmerich J
  Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Am J Gastroenterol. 2002 Jun;97(6):1438-45.
•   Hanauer SB, Smith MB
  Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol. 1993 May;88(5):646-9.
•   Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD
  Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006 Dec;49(12):1837-41.
•   Lapidus A, Bernell O, Hellers G, Löfberg R
  Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology. 1998 Jun;114(6):1151-60.
•   Lecomte T, Contou JF, Beaugerie L, Carbonnel F, Cattan S, Gendre JP, Cosnes J
  Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine. Dis Colon Rectum. 2003 Nov;46(11):1469-75.
•   Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, Block GE
  Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg. 1993 Nov;218(5):660-6.
•   Nivatvongs S, Gordon PH
  Crohn's Disease. In: Gordon PH, Nivatvongs S, editors. Principles and practice of surgery for the colon rectum and anus Third ed. New York: Informa Healthcare; 2007. p. 819-908.
•   Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A
  Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol. 2004 Mar;99(3):445-9.
•   Pearson DC, May GR, Fick GH, Sutherland LR
  Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995 Jul 15;123(2):132-42.
•   Poritz LS, Rowe WA, Koltun WA
  Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum. 2002 Jun;45(6):771-5.
•   Present DH, Lichtiger S
  Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci. 1994 Feb;39(2):374-80.
•   Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ
  Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999 May 6;340(18):1398-405.
•   Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS
  Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology. 2003 Aug;125(2):380-8.
•   Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ
  Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004 Feb 26;350(9):876-85.
•   Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ
  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002 Apr;122(4):875-80.
•   Thoreson R, Cullen JJ
  Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am. 2007 Jun;87(3):575-85. Review.

Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue

Details for clinical trial NCT01157650